An experimental new treatment is offering a beacon of hope for children suffering from a rare and severe form of epilepsy, with researchers suggesting it could enable them to "lead much healthier and happier lives".
Early trials of the drug zorevunersen have demonstrated a dramatic reduction in seizures among young patients with Dravet syndrome.
-copy-29e15046.jpeg?w=600)
